159 related articles for article (PubMed ID: 34593558)
1. Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis.
Willette RN; Mangrolia P; Pondell SM; Lee CYW; Yoo S; Rudoltz MS; Cowen BR; Welsch DJ
J Pharmacol Exp Ther; 2021 Nov; 379(3):290-300. PubMed ID: 34593558
[TBL] [Abstract][Full Text] [Related]
2. Amifostine ameliorates bleomycin-induced murine pulmonary fibrosis via NAD
Guo F; Xu F; Li S; Zhang Y; Lv D; Zheng L; Gan Y; Zhou M; Zhao K; Xu S; Wu B; Deng Z; Fu P
Eur J Med Res; 2024 Jan; 29(1):68. PubMed ID: 38245795
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated Protein Kinase-activated Protein Kinase 2 Inhibition Attenuates Fibroblast Invasion and Severe Lung Fibrosis.
Liang J; Liu N; Liu X; Mena JM; Xie T; Geng Y; Huan C; Zhang Y; Taghavifar F; Huang G; Kurkciyan A; Barron V; Jiang D; Noble PW
Am J Respir Cell Mol Biol; 2019 Jan; 60(1):41-48. PubMed ID: 30130411
[TBL] [Abstract][Full Text] [Related]
4. Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis.
Lee JH; Lee CM; Lee JH; Kim MO; Park JW; Kamle S; Akosman B; Herzog EL; Peng XY; Elias JA; Lee CG
Am J Respir Cell Mol Biol; 2022 Sep; 67(3):309-319. PubMed ID: 35679109
[TBL] [Abstract][Full Text] [Related]
5. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
6. HSPB1 inhibitor J2 attenuates lung inflammation through direct modulation of Ym1 production and paracrine signaling.
Oh A; Jeon S; Jeong MG; Kim HK; Kang J; Lee YS; Hwang ES
Biomed Pharmacother; 2021 Nov; 143():112225. PubMed ID: 34649353
[TBL] [Abstract][Full Text] [Related]
7. GED-0507 attenuates lung fibrosis by counteracting myofibroblast transdifferentiation in vivo and in vitro.
Speca S; Dubuquoy C; Rousseaux C; Chavatte P; Desreumaux P; Spagnolo P
PLoS One; 2021; 16(9):e0257281. PubMed ID: 34529707
[TBL] [Abstract][Full Text] [Related]
8. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
[TBL] [Abstract][Full Text] [Related]
9. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
[TBL] [Abstract][Full Text] [Related]
10. Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway.
Li L; Zhao J; Zhou L; Chen J; Ma Y; Yu Y; Cheng J
Respir Res; 2019 Jul; 20(1):163. PubMed ID: 31331325
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic disease.
Wilkinson AL; John AE; Barrett JW; Gower E; Morrison VS; Man Y; Pun KT; Roper JA; Luckett JC; Borthwick LA; Barksby BS; Burgoyne RA; Barnes R; Fisher AJ; Procopiou PA; Hatley RJD; Barrett TN; Marshall RP; Macdonald SJF; Jenkins RG; Slack RJ
Eur J Pharmacol; 2021 Dec; 913():174618. PubMed ID: 34762934
[TBL] [Abstract][Full Text] [Related]
12. Lysocardiolipin acyltransferase regulates TGF-β mediated lung fibroblast differentiation.
Huang LS; Jiang P; Feghali-Bostwick C; Reddy SP; Garcia JGN; Natarajan V
Free Radic Biol Med; 2017 Nov; 112():162-173. PubMed ID: 28751023
[TBL] [Abstract][Full Text] [Related]
13. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
[TBL] [Abstract][Full Text] [Related]
14. Metformin attenuates lung fibrosis development via NOX4 suppression.
Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
[TBL] [Abstract][Full Text] [Related]
15. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo.
Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW
Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129
[TBL] [Abstract][Full Text] [Related]
16. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
18. A long-acting isomer of Ac-SDKP attenuates pulmonary fibrosis through SRPK1-mediated PI3K/AKT and Smad2 pathway inhibition.
Qiu Y; Wang Z; Zhang X; Huang P; Zhang W; Zhang K; Wang S; He L; Guo Y; Xiang A; Zhang C; Hao Q; Li M; Li W; Zhang Y
IUBMB Life; 2020 Dec; 72(12):2611-2626. PubMed ID: 33135306
[TBL] [Abstract][Full Text] [Related]
19. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
[TBL] [Abstract][Full Text] [Related]
20. Alpha-lipoic acid attenuates silica-induced pulmonary fibrosis by improving mitochondrial function via AMPK/PGC1α pathway activation in C57BL/6J mice.
Chang M; Xu G; Xiong C; Yang X; Yan S; Tao Y; Li H; Li Y; Yao S; Zhao Y
Toxicol Lett; 2021 Oct; 350():121-132. PubMed ID: 34252510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
